TABLE 3

Characteristics of pediatric data used for model development

No.Age (years)GenderBody Weight (kg)Dose (mg/kg)Ross Score/NYHA Class
10.12Female3.10.093
20.13Male40.096
30.15Male3.90.093
40.5Female5.20.098
50.75Male80.093
61.25Male10.10.093
71.5Male9.50.0910
83.5Female13.10.093
95.5Male20.20.093
107.5Male24.30.095
118.25Male25.80.097
1211.6Female34.30.094
1311.8Male390.092
1417.5Male560.09NYHA II
1517.8Male610.09NYHA III
1619.3aMale98.20.09NYHA III
Mean6.726
S.D.6.7225.6
  • All patients were diagnosed with heart failure and were participants in the same clinical trial (Behn, 2001).

  • a Patient out of the pediatric age range according to guidelines set by World Health Organization.